The problem as always is the 2 extremes. What about somewhere in the middle?
Is this science really only worth $50M? Everything? Including NEO and AXAL? That's the current value the market is assigning to it once you subtract cash, receivables, and assets.
Even if one believes that this truly wretched BOD and the lackeys they install in senior management positions aren't capable of ever getting the valuation up to KITE / JUNO levels...is there still enough real there to believe some company could ante up maybe $750M to $1B for this at some point?